Literature DB >> 1263116

The effects of phencyclidine, ketamine, delta-amphetamine and pentobarbital on schedule-controlled behavior in the mouse.

G R Wenger, P B Dews.   

Abstract

The response of mice of breaking a light beam onto a photocell was programmed to produce food according to a multiple schedule with alternating 30-response fixed ratio, 300-second fixed interval (FR-30 FI-300 sec) components. Training was standardized for all mice, and stable patterns of responding that were similar to those described for other species and responses under this schedule developed quickly. The effects of pentobaribtal, delta-amphetamine, phencyclidine and ketamine were studied. At some dose, each of the four drugs produced an increase in rate of responding; the increase was proportionately greater at low rates of responding than at higher rates. At some dose range, delta-amphetamine, ketamine and phencyclidine produced dose-related increases in FI average rates were to 1.83, 1.25 and 1.32 times the control rate for delta-amphetamine (1 mg/kg), ketamine (100 mg/kg) and phencyclidine (3 mg/kg), respectively. Phencyclidine and ketamine thus showed some "amphetamine-like" effects in the mouse. Pentobarbital increased (1.25 times the control rate) both the FR and FI response rates at a dose of 3 mg/kg. Higher doses of pentobarbital progressively decreased both FR and FI response rates in a parallel fashion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1263116

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  Situational specificity of tolerance to effects of phencyclidine on responding of rats under fixed-ratio and spaced-responding schedules.

Authors:  J B Smith
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Studies on responding under fixed-interval schedules of reinforcement: II. The scalloped pattern of the cumulative record.

Authors:  P B Dews
Journal:  J Exp Anal Behav       Date:  1978-01       Impact factor: 2.468

3.  The Return of Rate Dependence.

Authors:  Amanda J Quisenberry; Sarah E Snider; Warren K Bickel
Journal:  Behav Anal (Wash D C)       Date:  2016-11

4.  Comparison of antidepressant-like and abuse-related effects of phencyclidine in rats.

Authors:  Todd M Hillhouse; Joseph H Porter; S Stevens Negus
Journal:  Drug Dev Res       Date:  2014-10-15       Impact factor: 4.360

5.  Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists.

Authors:  Patrick A Randall; Eric J Nunes; Simone L Janniere; Colin M Stopper; Andrew M Farrar; Thomas N Sager; Younis Baqi; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2011-02-24       Impact factor: 4.530

6.  Effects of clonidine and some alpha-adrenergic antagonists alone and in combination on schedule-controlled behavior in pigeons and mice.

Authors:  J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Reinforcement magnitude modulation of rate dependent effects in pigeons and rats.

Authors:  Brett C Ginsburg; Jonathan W Pinkston; R J Lamb
Journal:  Exp Clin Psychopharmacol       Date:  2011-08       Impact factor: 3.157

8.  Effects of d-amphetamine, cocaine, and phencyclidine on the acquisition of response sequences with and without stimulus fading.

Authors:  J M Moerschbaecher; D M Thompson
Journal:  J Exp Anal Behav       Date:  1980-05       Impact factor: 2.468

9.  Psychomotor stimulant effects of d-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice.

Authors:  K A Miczek; M Haney
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

10.  The generality of nicotine as a reinforcer enhancer in rats: effects on responding maintained by primary and conditioned reinforcers and resistance to extinction.

Authors:  Bethany R Raiff; Jesse Dallery
Journal:  Psychopharmacology (Berl)       Date:  2008-08-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.